News

Patients suffering from these severe gout indications accumulate uric acid deposits in joints and tissues, which can cause debilitating pain and damage to joints and organs. SEL-212, the

The randomized, double-blind, placebo-controlled, registration-quality Phase 2 clinical trial AtEase is being conducted at about 25 US sites. The study has been designed to assess the safety of

L-DOS47 is the company’s first immunoconjugate based drug candidate in development based on its DOS47 platform technology designed to use a new approach to amend the microenvironmental conditions

The phase 1/2 open-label, multi-center, clinical trial is for patients with CD30-expressing relapsed or refractory B-cell and T-cell non-Hodgkin lymphomas (NHL), including diffuse large B-cell lymphoma (DLBCL), peripheral

The ongoing phase-2 clinical trial investigates the safety and efficacy of ACP-01, which uses angiogenic progenitor cells to combat the life-threatening complications of CLI. These proprietary cells are

The agreement was executed based on a series of studies using validated animal models of CIPN exposed to unique cannabinoid-based therapies conducted in the lab of Dr. Kenneth

The amendment includes a change in primary endpoint to overall survival to enable a potential registration opportunity for MM-121. Merrimack president and CEO Robert Mulroy said: "We believe

Vanda president and CEO Mihael Polymeropoulos said: "The MAA validation demonstrates Vanda’s commitment to offer another option to the healthcare community to treat a severe, disabling mental disorder.

In the pivotal clinical trial, rVIII-SingleChain met all primary endpoints. Hemophilia A is a congenital bleeding disorder characterized by deficient or defective factor VIII; nearly all affected patients